Department of Anesthesiology, Pain Clinic, University Medical Center Utrecht, Utrecht, The Netherlands.
Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Pain Pract. 2021 Apr;21(4):468-481. doi: 10.1111/papr.12974. Epub 2020 Dec 26.
Low-back or leg pain in patients suffering from failed back surgery syndrome (FBSS) is often severe, having a major impact on functionality and quality of life. Despite conservative and surgical treatments, pain can be persistent. An alternative treatment option is epiduroscopy, a minimally invasive procedure based on mechanical adhesiolysis of epidural fibrosis. As epidural fibrosis is speculated to be a major contributor in the pathophysiologic process of FBSS, this review evaluates the effectiveness of epiduroscopy in FBSS patients.
A systematic literature search was performed in PubMed, Embase, and Cochrane databases. Critical appraisal was performed using validated tools. Meta-analysis was performed using generic inverse variance analysis.
From the 286 identified articles, nine studies were included. The visual analogue scale (VAS) average was 7.6 at baseline, 4.5 at 6, and 4.3 at 12 months. The Oswestry Disability Index (ODI) average was 61.7% at baseline, 42.8% at 6, and 46.9% at 12 months. An average of 49% of patients experienced significant pain relief at 6 and 37% at 12 months. Meta-analysis showed a pooled VAS mean difference of 3.4 (2.6 to 4.1; 95% confidence interval [CI]) and 2.8 (1.6 to 4.0; 95% CI) and pooled ODI mean difference of 19.4% (12.5 to 26.4%; 95% CI) and 19.8% (13.8 to 25.9%; 95% CI) at 6 and 12 months, respectively.
Current literature demonstrates a clinically relevant reduction in pain and disability scores at 6 to 12 months after mechanical adhesiolysis in FBSS patients. The quality of evidence is moderate, and the level of recommendation is weak. Practitioners should consider the benefits of epiduroscopy after weighing the risks for individual patients with FBSS.
患有失败性腰椎术后综合征(FBSS)的患者通常会出现严重的下腰痛或下肢痛,这对其功能和生活质量有重大影响。尽管进行了保守和手术治疗,疼痛仍可能持续存在。一种替代治疗方法是硬膜外镜检查,这是一种基于硬膜外纤维化的机械松解的微创手术。由于硬膜外纤维化被认为是 FBSS 病理生理过程中的主要因素,因此本综述评估了硬膜外镜检查在 FBSS 患者中的有效性。
在 PubMed、Embase 和 Cochrane 数据库中进行了系统文献检索。使用经过验证的工具进行了批判性评估。使用通用逆方差分析进行了荟萃分析。
从 286 篇已识别的文章中,纳入了 9 项研究。视觉模拟评分(VAS)基线平均为 7.6,6 个月时为 4.5,12 个月时为 4.3。Oswestry 残疾指数(ODI)基线平均为 61.7%,6 个月时为 42.8%,12 个月时为 46.9%。平均有 49%的患者在 6 个月时有显著的疼痛缓解,37%的患者在 12 个月时有显著的疼痛缓解。荟萃分析显示,VAS 平均差值为 3.4(2.6 至 4.1;95%置信区间[CI])和 2.8(1.6 至 4.0;95% CI),ODI 平均差值为 19.4%(12.5 至 26.4%;95% CI)和 19.8%(13.8 至 25.9%;95% CI),分别在 6 个月和 12 个月时。
目前的文献表明,在 FBSS 患者中,进行机械松解后 6 至 12 个月,疼痛和残疾评分有明显的降低。证据质量为中等,推荐等级为弱。临床医生应在权衡 FBSS 患者个体风险后,考虑硬膜外镜检查的益处。